CBU
UTHR icon

CIBC Bancorp USA’s United Therapeutics UTHR Stock Holding History

CIBC Bancorp USA’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Sell
2,689
-60
-2% -$33.8K ﹤0.01% 1011
2026
Q1 		$1.63M Buy
+2,749
New +$1.37M ﹤0.01% 944
2025
Q3 		$644K Buy
+1,536
New +$517K ﹤0.01% 778

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

CIBC Bancorp USA's UTHR Position: Q2 2026 in Review

CIBC Bancorp USA reduced its United Therapeutics (UTHR) stake by 2.2% in Q2 2026, selling an estimated $33.8K and leaving 2,689 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

CIBC Bancorp USA first reported a position in UTHR in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.63M in Q1 2026. 818 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • CIBC Bancorp USA held 2,689 shares of United Therapeutics worth $1.46M as of Q2 2026.
  • CIBC Bancorp USA sold 60 United Therapeutics shares in Q2 2026, an estimated $33.8K.
  • United Therapeutics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1011 holding.
  • CIBC Bancorp USA first reported a position in United Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's United Therapeutics position peaked at $1.63M in Q1 2026.
  • 818 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.